About Paladin Labs (TSE:PLB)
Paladin Labs Inc. is a specialty pharmaceutical company focused on developing, acquiring, in-licensing, marketing and distributing pharmaceutical products. The Company's product portfolio includes Tridural, Abstral and Trelstar. Tridural is a once-a-day tramadol product indicated as a first-line therapy for adults with moderate pain requiring several days or more of treatment. Abstral is a sublingual tablet used for the management of breakthrough cancer pain in patients who are already tolerant to other opioid analgesics. Trelstar is an injectable, luteinizing hormone releasing hormone agonist indicated for the palliative treatment of prostate cancer and endometriosis. In July 2013, the Company became the sole holder of Allon Therapeutics Inc. In September 2013, Blackstar Group SE announced that it has sold remaining 13.4% interests in Litha Healthcare Group Limited (Litha) to Paladin Labs Inc. Effective January 1, 2014, Paladin Labs Inc. acquired Triton Pharma Inc.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Paladin Labs (TSE:PLB) Frequently Asked Questions
What is Paladin Labs' stock symbol?
Paladin Labs trades on the Toronto Stock Exchange (TSX) under the ticker symbol "PLB."
Who are some of Paladin Labs' key competitors?
Some companies that are related to Paladin Labs include Royal Bank of Canada (RY), Toronto-Dominion Bank (TD), Bank of Nova Scotia (BNS), Enbridge (ENB), Suncor Energy (SU), Canadian National Railway (CNR), Bank of Montreal (BMO), Canadian Natural Resources (CNQ), Canadian Imperial Bank of Commerce (CM), Manulife Financial (MFC), Brookfield Asset Management (BAM.A), TransCanada (TRP), BCE (BCE), Thomson Reuters (TRI), Alimentation Couche-Tard (ATD.A), Alimentation Couche-Tard (ATD.B), Restaurant Brands International (QSR) and Great-West Lifeco (GWO).
How do I buy Paladin Labs stock?
Shares of Paladin Labs and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
How can I contact Paladin Labs?
Paladin Labs' mailing address is 100 Alexis-Nihon Blvd Suite 600, SAINT-LAURENT, QC H4M 2P2, Canada. The specialty pharmaceutical company can be reached via phone at +1-514-3401112.
MarketBeat Community Rating for Paladin Labs (PLB)MarketBeat's community ratings are surveys of what our community members think about Paladin Labs and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Paladin Labs (TSE:PLB) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Paladin Labs (TSE:PLB) Earnings History and Estimates Chart
Paladin Labs (TSE PLB) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Paladin Labs (TSE:PLB) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Paladin Labs (TSE:PLB)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Paladin Labs (TSE PLB)
No insider trades for this company have been tracked by MarketBeat.com
Paladin Labs (TSE PLB) News Headlines
Paladin Labs (TSE:PLB) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Paladin Labs (TSE PLB) Stock Chart for Friday, January, 19, 2018